PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Colon, Sigmoid”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources
PubMed1983

Buerger's disease of the sigmoid colon.

Buerger's disease of the sigmoid colon is reported. This is an unusual site of involvement by the disease. Review of the literature has revealed only four other cases.

Colon, Sigmoid↗
PubMed2004

The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer.

BACKGROUND AND PURPOSE: In radiotherapy for prostate cancer, the rectum is considered the dose-limiting organ. The incidence of overlap between the sigmoid colon and/or small bowel and the planning target volume (PTV) as well as the dose to sigmoid colon and small bowel were investigated. PATIENTS AND METHODS: The CT data of 75 prostate cancer patients were analyzed. The clinical target volume (CTV) consisted of prostate and seminal vesicles. The PTV was defined as a three-dimensional expansion of the CTV with a 10-mm margin in craniocaudal and a 7-mm margin in the other directions. All patients were planned to a mean CTV dose of at least 76 Gy. Minimum CTV dose was set at 70 Gy. Dose inhomogeneity within the CTV was kept between 12% and 17%. Sigmoid colon was defined upward from the level where the rectum turned in a transverse plane. Contrast-filled small bowel was contoured on all slices where it was visible. The presence of sigmoid colon and/or small bowel in close vicinity to or overlapping with the PTV was recorded. For each case, the dose to the sigmoid colon and small bowel was calculated. RESULTS: The PTV was found to overlap with the sigmoid colon in 60% and with the small bowel in 19% of the cases. In these patients, mean maximum dose to the sigmoid colon was 76.2 Gy (5th-95th percentile: 70.0-80.7 Gy). Mean maximum dose to the small bowel was 74.9 Gy (5th-95th percentile: 68.0-80.0 Gy). CONCLUSION: When systematically investigating the anatomic position of sigmoid colon and small bowel in patients accepted for prostate irradiation, parts of both organs were often observed in close vicinity to the PTV. Apart from the rectum, these organs may be dose-limiting in prostate radiotherapy.

Adenocarcinoma↗
PubMed1990

[Immunohistochemical studies on Lewis blood group antigens in carcinomas and adenomas of the sigmoid colon and rectum].

The presence of Lewis blood group antigens (Lewis(a), Lewis(b)) was determined immunohistochemically in 75 carcinomas and 58 adenomas of the sigmoid colon and rectum. 1. The rate of positive Lewis(b) staining of adult normal mucosa was 100% in the ascending colon, 100% in the transverse colon, 25% in the sigmoid colon and 30% in the rectum, respectively. The incidence of Lewis(b) was high in the proximal colon but low in the sigmoid colon and rectum. 2. The rate of positive Lewis(b) staining was 97% in cancer, 57% in adenoma and 26% in normal mucosa, respectively. The difference between the incidence of positive Lewis(b) staining in normal mucosa, and those in cancer and adenoma was significant (p less than 0.01). 3. The rate of positive Lewis(b) staining was 42% in mild and moderate dysplastic adenoma and 68% in severe dysplastic adenoma. There was a significant difference between the percentage of Lewis(b) staining in mild or moderate dysplastic adenoma and that of severe dysplastic adenoma (p less than 0.05). The expression of Lewis(b) antigen correlated with the size of adenoma. These results suggest that Lewis(b) antigen has a cancer-associated nature and Lewis(b) staining might be useful as an indicator of malignant potential of adenoma of the sigmoid colon and rectum.

Adenocarcinoma↗